Pharmacological or genetic inactivation of STAT3 inhibits TGFβ-induced fibroblast-to-myofibroblast transition and collagen release in cultured fibroblasts and ameliorates skin fibrosis in two mouse models of SSc. The gene discussed is TGFB1; the disease is systemic sclerosis.